With its ascent seemingly unstoppable in the last few years, automated cell therapy manufacturer Cellares is facing some ...

Daiichi Sankyo is promoting Ken Keller to lead a new globally integrated commercialization unit, putting the executive in ...

Move over, Hollywood—the real stars of the show are the ones helping patients in hospitals across the country.  | Education ...

After more than 10 years in development, Regeneron secured a landmark approval for its monoclonal antibody garetosmab, now ...

For patients living with Type 2 diabetes in the United Kingdom, a more convenient treatment option may be on the horizon ...

Eight months after more than doubling down on its construction of a $2 billion drug manufacturing facility in Holly Springs, ...

With a massive array of prescription drugs losing patent protection in the coming years, including many biologics, Sandoz has ...

B. Braun Medical—a maker of IV solutions for hospitals, among other products—has initiated a recall in the United States and ...

Just eight months after it introduced its oral version of semaglutide for obesity, also known as the Wegovy pill, Novo ...

China's investigator-initiated trials, once praised for their speediness, have been drawn into scrutiny for a lack of ...

Less than a year after the FDA turned down the resubmitted application for the company’s leukemia prospect Dasynoc, Xspray ...

If at first you don’t succeed in gene therapy, then try, try again. | If at first you don’t succeed in gene therapy, then try ...